Arvinas Inc (NAS:ARVN)
$ 31.44 -0.51 (-1.6%) Market Cap: 2.15 Bil Enterprise Value: 984.80 Mil PE Ratio: 0 PB Ratio: 3.52 GF Score: 79/100

Arvinas Inc at Bank of America Global Healthcare Conference Transcript

May 09, 2023 / 10:40PM GMT
Release Date Price: $24.21 (-1.86%)
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst

All right. Good afternoon, everybody. Thanks so much for joining us at the Bank of America Healthcare Conference. I am Tazeen Ahmad, I'm one of the Smid biotech analyst here. It's my pleasure to have our next presenting company, management with us from Arvinas. I have 2 members from the team sitting right next to me on my right is Sean Cassidy, who is, of course, Chief Financial Officer. And to my left is Randy Teel, who handles Corporate and Business Development. Gentlemen, good afternoon. Thanks for coming out here to Vegas to join us at the conference.

Randy Teel
Arvinas, Inc. - SVP of Corporate & Business Development

Thanks for having us.

Sean A. Cassidy;Tazeen Ahmad
Arvinas, Inc. - CFO, Principal Financial Officer & Treasurer;BofA Securities,

Yes, thanks for having us and Randy is going to wear another hat today, Chief Medical Officer for a good portion of these questions.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot